Dr. Carly Whyte
Dr Carly Whyte completed her Bachelor of Science (Biomedical Science) (First Class Honours) at the University of Adelaide. In 2018, Carly obtained her PhD at the University of Adelaide, where she uncovered a novel mechanism of how T cell migration into tumours is controlled. Carly then undertook postdoctoral training at the Babraham Institute in Cambridge, UK, where she investigated context-dependent effects of the immune-modulating cytokine IL-2, with a view to improve therapeutic outcomes for patients with immune-mediated diseases. Carly has presented her research at national and international conferences and has published numerous articles in high-impact journals.
Carly has recently joined the Centre for Cancer Biology at the University of South Australia where she is investigating the therapeutic potential of manipulating eosinophils in head and neck cancer with the support of a Junior Fellowship from GPRWMF.
Other GPRWMF awards received by awardee | Year | |
---|---|---|
Junior Fellowship | Defining the therapeutic potential of eosinophils in head and neck cancer | 2022 |